Inhibition of MHC class I antigen presentation by viral proteins

Journal of Molecular Medicine

Volumn 75, Issue 1, 1997, Pages 18-27

  Fruh K ^a   Ahn, K ^a   Peterson, P A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

adenovirus; antigen presentation; herpesvirus; histocompatibility

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS PROTEIN;

ANTIGEN PRESENTATION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; REVIEW; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS;

ANIMALS; ANTIGEN PRESENTATION; CYTOMEGALOVIRUS; FORECASTING; HERPESVIRIDAE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 0031030954     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050082     Document Type: Review

References (110)

1. Jackson MR, Peterson PA (1993) Assembly and intracellular transport of MHC class I molecules. Annu Rev Cell Biol 9: 207-235
2. Parham P, Adams EJ, Arnett KL (1995) The origins of HLA A, B, C polymorphism. Immunol Rev 143:141-180
3. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506-512
4. Fremont DH, Stura EA, Matsumura M, Peterson PA, Wilson IA (1995) Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci USA 92:2479-2483
5. Rammensee HG, Falk K, Rötschke O (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11:213-244
6. Rechsteiner M, Hoffman L, Dubiel W (1993) The multicatalytic and 26 S proteases. J Biol Chem 268:6065-6068
7. Löwe J, Stock D, Jap B, Zwickl P, Baumeister W, Huber R (1995) Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Å resolution. Science 268: 533-539
8. Morimoto Y, Mizushima T, Yagi A, Tanahashi N, Tanaka K, Ichihara A, Tsukihara T (1995) Ordered structure of the crystallized bovine 20S proteasome. J Biochem 117:471-474
9. Seemüller E, Lupas A, Stock D, Löwe J, Huber R, Baumeister W (1995) Proteasomes from Thermoplasma acidophilum: a threonine protease. Science 268:579-582
10. Driscoll J, Goldberg AL (1990) The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins. J Biol Chem 265:4789-4-792
11. Gordon C, McGurk G, Dillon P, Rosen C, Hastie ND (1993) Defective mitosis due to a mutation in the gene for a fision yeast 26S protease subunit. Nature 366:355-357
12. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685
13. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T (1994) The ubiquitin-proteasome pathway is required for processing the NF-kappaB1 precursor protein and the activation of NF-kappaB. Cell 78:773-785
14. Chen P, Hochstrasser M (1995) Biogenesis, structure and function of the yeast 20S proteasome. EMBO J 14:2620-2630
15. Deveraux Q, Ustrell V, Pickart C, Rechsteiner M (1994) A 26 S protease subunit that binds ubiquitin conjugates. J Biol Chem 269:7059-7061
16. Jennissen (1995) Ubiquitin and the enigma of intracellula protein degradation. Eur J Biochem 231:1-30
17. Michaelek MT, Grant EP, Gramm C, Goldberg AL, Rock KL (1993) A role for the ubiquitin dependent proteolytic pathway in MHC class 1-restricted antigen presentation. Nature 363:552-554
18. Cox JH, Galardy P, Bennink JR, Yewdell JW (1995) Presentation of endogenous and exogenous antigens is not affected by inactivation of E1 ubiquitin-activating enzyme in temperature-sensitive cell lines. J Immunol 154:511-519
19. Monaco JJ, Nandi D (1995) The genetics of proteasomes and antigen processing. Annu Rev Genet 29:729-754
20. Früh K, Gossen M, Wang K, Bujard H, Peterson PA, Yang Y (1994) Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J 13:3236-3244
21. Belich MP, Glynne RJ, Senger G, Sheer D, Trowsdale J (1994) Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins. Curr Biol 4:769-776
22. Akiyama K, Kagawa S, Tamura T, Shimbara N, Takashina M, Kristensen P, Hendil KB, Tanaka K, Ichihara A (1994) Replacement of proteasome subunits X and Y by LMP7 and LMP2 induced by interferon-gamma for acquirement of the functional diversity responsible for antigen processing. FEBS Lett 343:85-88
23. Lehner PJ, Cresswell P (1996) Processing and delivery of peptides presented by MHC class 1 molecules. Curr Op Immunol 8:59-67
24. Van Kaer L, Ashton-Rickard PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, Goldberg AL, Doherty PC, Tonegawa S (1994) Altered peptidase and viral-specific T cell response in mice lacking proteasome subunit LMP-7. Immunity 1:533-541
25. Fehling HJ, Swat W, Laplace C, Kühn R, Rajewsky K, Müller U, Von Boehmer H (1994) MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265: 1234-1237
26. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771
27. Hughes EA, Ortmann B, Surman M, Cresswell P (1996) The protease inhibitor, N-acetyl-L-leucyl- L-leucyl- L-norleucinal, decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum. J Exp Med 183:1569-1578
28. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL (1995) Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726-731
29. Townsend A, Trowsdale J (1993) The transporters associated with antigen presentation. Sem Cell Biol 4:53-61
30. Levy F, Gabathuler R, Larsson R, Kvist S (1991) ATP is required for in vitro assembly of MHC class I antigens but not for transfer of peptides across the ER membrane. Cell 67: 265-274
31. Neefjes JJ, Momburg F, Hämmerling GJ (1993) Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261:769-771
32. Shepherd JC, Schumacher TNM, Ashton-Riekardt PG, Imaeda S, Ploegh H, Janeway CA, Tonegawa S (1993) TAP1-dependent peptide translocation in vitro is ATP-dependent and selective. Cell 74:577-584
33. Androlewicz MJ, Anderson KS, Cresswell P (1993) Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci U S A 90:9130-9134
34. Kelly A, Powis SH, Kerr L-A, Mockridge I, Elliott T, Bastin J, Uchanska-Ziegler B, Ziegler A, Trowsdale J, Townsend A (1992) Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 355:641-44
35. Spies T, Bresnahan M, Bahram S, Arnold M, Blanck G, Mellins E, Pious D, DeMars R (1990) A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 348:744-747
36. Townsend A, Ohlén C, Bastin J, Ljunggren H-G, Foster L, Karre K (1989) Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340:443-448
37. Yang Y, Früh K, Chambers J, Waters JB, Wu L, Spies T, Peterson PA (1992) Major histocompatibility complex (MHC)-encoded HAM2 is necessary for peptide loading onto class I MHC molecules. J Biol Chem 267:11669-11672
38. Spies T, DeMars R (1991) Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 351:323-324
39. Powis SJ, Townsend ARM, Deverson EV, Bastin J, Butcher W, Howard JC (1991) Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature 354:528-531
40. Van Kaer L, Ashton-Riekardt PG, Ploegh H, Tonegawa S (1992) TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell 71: 1205-1214
41. De la Salle H, Hanau D, Fricker D, Urlacher A, Kelly A, Salamero J, Powis SH, Donato L, Bausinger H, Laforet M, Jeras M, Spehner D, Bieber T, Falknerodt A, Caszenave J-P, Trowsdale J, Tongio M-M (1994) Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265:237-241
42. Momburg F, Roelse J, Hämmerling GJ, Neefjes JJ (1994) Peptide size selection by the major histocompatibility complex-encoded peptide transporters. J Exp Med 179:1613-1623
43. Schumacher TN, Kantesaria DV, Heemels MT, Ashton-Rickardt PG, Shepherd JC, Fruh K, Yang Y, Peterson PA, Tonegawa S, Ploegh HL (1994) Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J Exp Med 179: 533-540
44. Powis SJ, Deverson EV, Coadwell WJ, Ciruela A, Huskisson NS, Smith H, Butcher GW, Howard JC (1992) Effect of polymorphism of an MHC-linked transporter on peptides assembled in a class I molecule. Nature 357:211-215
45. Heemels MT, Schumacher TN, Wonigeit K, Ploegh HL (1993) Peptide translocation by variants of the transporter associated with antigen processing. Science 262:2059-2063
46. Androlewicz MJ, Ortmann B, Van Endert PM, Spies T, Cresswell P (1994) Characteristics of peptide and major histocompatibility complex class I/beta2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2). Proc Natl Acad Sci U S A 91:12716-12720
47. Van Endert PM, Tampé R, Meyer TH, Tisch R, Bach J-F, McDevitt HO (1994) A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity 1:491-500
48. Wang K, Früh K, Peterson PA, Yang Y (1994) Nucleotide binding of the C-terminal domains of the major histocompatibility complex-encoded transporter expressed in Drosophila melanogaster cells. FEBS Lett 350:337-341
49. Müller KM, Ebensperger C, Tampé R (1994) Nucleotide binding to the hydrophilic C-terminal domain of the transporter associated with antigen processing (TAP). J Biol Chem 269:14032-14037
50. Suh WK, Cohen-Doyle MF, Früh K, Wang K, Peterson PA, Williams DB (1994) Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264:1322-1326
51. Ortmann B, Androlewicz MJ, Cresswell P (1994) MHC class I/β2-microglobulin complexes asociate with transporters before peptide binding. Nature 368:864-867
52. Grandea A, III, Androlewicz MJ, Athwal RS, Geraghty DE, Spies T (1995) Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 270: 105-108
53. Koup RA (1994) Virus escape from CTL recognition. J Exp Med 180:779-782
54. Spriggs MK (1996) One step ahead of the game: viral immunomodulatory molecules. Annu Rev Immunol 14:101-130
55. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG (1995) Inhibition of antigen processing by the integral repeat region of the Ebstein-Barr virus nuclear antigen-1. Nature 375:685-688
56. Rotem-Yehudar R, Winograd S, Sela S, Coligan JE, Ehrlich R (1994) Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12. J Exp Med 180:477-488
57. Rotem-Yehudar R, Groettrup M, Soza A, Kloetzel P, Ehrlich R (1996) LMP-associated proteolytic activities and TAP-dependent peptide transport for class I MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12. J Exp Med 183:499-514
58. McFadden G, Kane K (1993) How DNA viruses perturb functional MHC expression to alter immune recognition. Adv Cancer Res 63:117-209
59. Burgert H-G, Kvist S (1985) An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41:987-997
60. Andersson M, Pääbo S, Nilsson T, Peterson PA (1985) Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43:215-222
61. Jackson MR, Nilsson T, Peterson PA (1990) Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J 9:3153-3162
62. Letourneur F, Gaynor EC, Hennecke S, Démoliere C, Dude R, Emr S, Riezman H, Cosson P (1994) Coatomer is essential for retrieval of dilysine-tagged proteins to the endoplasmic reticulum. Cell 79:1199-1207
63. Teasdale RD, Jackson MR (1996) Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the golgi apparatus. Ann Rev Cell Dev Biol (in press)
64. Cox JH, Bennink JR, Yewdell JW (1991) Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J Exp Med 174:1629
65. Beier DC, Cox JH, Vining DR, Cresswell P, Engelhard VH (1994) Association of human class I MHC alleles with the adenovirus E3/19 K protein. J Immunol 152:3862-3872
66. Pääbo S, Weber F, Nilsson T, Schaffner W, Peterson PA (1986) Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein. EMBO J 5:1921-1927
67. Burgert HG, Kvist S (1987) The E3/19 K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. EMBO J 6:2019-2026
68. Deryckere F, Burgert H-G (1996) Early region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinction of that of subgroups B and C. J Virol 70:2832-2841
69. Hermiston TW, Tripp RA, Sparer T, Gooding ER, Wold WSM (1993) Deletion mutation analysis of the adenovirus type 2 E3-gp19 K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-speeific cytotoxic T lymphocytes. J Virol 67:5289-5298
70. Feuerbach D, Burgert HG (1993) Novel proteins associated with MHC class 1 antigens in cells expressing the adenovirus protein E3/19 K. Embo J 12:3153-3161
71. Jennings SR, Rice PE, Kloszewski ED, Anderson RW, Thompson DE, Tevethia SS (1985) Effect of Herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility antigens on infected cells. J Virol 56:757-766
72. Hill AB, Barnett BC, McMichael AJ, McGeoch DJ (1994) HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types I and 2. J Immunol 152:2736-2741
73. York IA, Roop C, Andrews DW, Riddell SR, Graham FE, Johnson DC (1994) A cytosolic herpes simplex protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77:525-535
74. Jackson MR, Früh K, Karlsson E, Teyton E, Yang Y, Peterson PA (1995) Assembly and intracellular transport of MHC class I and class II molecules. Cold Spring Harbor Laboratory Symposia on Quantitative Biology LX
75. Früh K, Ahn K, Djaballah H, Sempé P, van Enden PM, Tampé R, Peterson PA, Yang Y (1995) A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415-418
76. Hill A, Jugovic P, York I, Rus G, Bennink J, Yewdell J, Ploegh H, Johnson D (1995) Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411-415
77. Tomazin R, Hill AB, Jugovic P, York I, van Endert P, Ploegh HL, Andrews DW, Johnson D (1996) Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J 15:3256-3266
78. Ahn K, Meyer TH, Uebel S, Sempé P, Djaballah H, Yang Y, Peterson PA, Früh K, Tampé R (1996) Molecular mechanism and species specificity of TAP inhibition by Herpes simplex virus protein 1CP47. EMBO J 15:3247-3255
79. Uebel S, Meyer TM, Kraas W, Kienle S, Jung G, Wiesmüller K-H, Tampé R (1995) Requirements for peptide binding to the human transporter associated with antigen processing (TAP) revealed by peptide scans and complex libraries. J Biol Chem 270:18512-18516
80. Momburg F, Armandola EA, Post M, Hammerling GJ (1996) Residues in TAP2 peptide transporters controlling substrate specificity. J Immunol 156:1756-1763
81. Nijenhuis M, Schmitt S, Armandola EA, Obst R, Brunner J, Hammerling GJ (1996) Identification of a contact region for peptide on the TAP1 chain of the transporter associated with antigen processing. J Immunol 156:2186-2195
82. Beersma MFC, Bijlmakers MJE, Ploegh H (1993) Human cytomegalovirus downregulates HLA class I expression by reducing the stability of class I H chains. J Immunol 151: 4455-4464
83. Warren AP, Ducroq DH, Lehner PJ, Borysiewicz EK (1994) Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes. J Virol 68:2822-2829
84. Yamashita Y, Shimokata K, Saga S, Mizuno S, Tsurumi T, Nishiyama Y (1994) Rapid degradation of the heavy chain of class I major histocompatibility complex antigens in the endoplasmic reticulum of human cytomegalovirus-infected cells. J Virol 68:7933-7943
85. Jones TR, Hanson LK, Sun L, Slater JS, Stenberg RM, Campbell AE (1995) Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompalibility complex class 1 heavy chains. J Virol 69:4830-4841
86. Wiertz EJHJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL (1996) The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the ER to the cytosol. Cell 84:769-779
87. Jones TR (1996) Identification of a human cytomegalovirus gene US2 involved in down-regulation of MHC class I heavy chain expression, recombinant deletion mutant virus for vaccine, and vector for gene therapy. PCT Int Appl
88. Ahn K, Angulo A, Ghazal P, Peterson PA, Yang Y, Früh K (1996) Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci U S A (in press)
89. Thäle R, Szepan U, Hengel H, Geginat G, Lucin P, Koszinowski UH (1995) Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J Virol 69:6098-6105
90. Del Val M, Hengel H, Hacker H, Hartlaub U, Ruppert T, Lucin P, Koszinowski UH (1992) Cytomegalovirus prevents antigen presentation by blocking transport of peptide-loaded major histocompalibility complex class I moleucles into the medial golgi compartment. J Exp Med 176:729-738
91. Hill A, Kleijnen M, Schust D, Koszinowski U, Ploegh H (1996). Murine cytomegalovirus (MCMV) encodes a 34 kDa glycoprotein which binds to class I MHC molecules at the surface of infected cells (abstract 410). In: (eds) Cell biology of virus entry, replication and pathogenesis. Keystone Symposium, Santa Fe
92. Kärre K (1993) Natural killer cells and the MHC class I pathway of peptide presentation. Sem Immunol 5:127-145
93. Lanier LL, Phillips JH (1996) Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 17:86-91
94. Brutkiewiecz RR, Welsh RM (1995) Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J Virol 69:3967-3971
95. Fahnestock ML, Johnson JL, Feldman RMR, Neveu JM, Lane WS, Bjorkman PJ (1995) The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3:583-590
96. Browne H, Smith G, Beck S, Minson T (1990) A complex between the MHC class I homologue encoded by human cytomegalovirus and b2 microglobulin. Nature 347:770-772
97. Browne H, Churcher M, Minson T (1992) Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted. J Virol 66:6784-6787
98. Mester JC, Rouse B (1991) The mouse model and understanding immunity to herpes simplex virus. Rev Inf Dis 13 [Suppl 11]:S935-945
99. Reddehase MJ, Mutter W, Munch K, Buhring HJ, Koszinowski UH (1987) CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 61:3102-3108
100. Hengel H, Lucin P, Jonjic S, Ruppert T, Koszinowski UH (1994) Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J Virol 68:289-297
101. Hengel H, Esslinger C, Pool J, Goulmy E, Koszinowski UH (1995) Cytokines restore MHC class I complex formation and control antigen presentation in human cytomecalovirus-infected cells. J Gen Virol 76:2987-2997
102. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD (1992) Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238-241
103. Maccario R, Revello MG, Comoli P, Montagna D, Locatelli F, Gerna G (1993) HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes. J Immunol 150: 1437-1445
104. Tigges MA, Leng S, Johnson DC, Burke RL (1996) Human herpes simplex virus (HSV)-specific CDS+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-γ or when virion host shutoff functions are disabled. J Immunol 156:3901-3910
105. Ginsberg HS, Lundholm-Beauchamp U, Horswood RL, Pernis B, Wold WS, Chanock RM, Prince GA (1989) Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci U S A 86:3823-7
106. Sparer TE, Tripp RA, Dillehay DL, Hermiston TW, Wold WSM, Gooding L (1996) The role of human adenovirus early region 3 proteins (gp19 K, 10.4 K, 14.5 K, and 14.7 K) in a murine pneumonia model. J Virol 70:2431-2439
107. Horwitz MS, Tufariello J, Grunhaus A, Fejer G (1995) Model systems for studying the effects of adenovirus E3 genes on virulence in vivo. Curr Top Microbiol Immunol 199:195-211
108. Yang Y, Ertl CJ, Wilson JM (1994) MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses. Immunity 1:433-442
109. De Bruijn ML, Schumacher TN, Nieland JD, Ploegh HL, Kast WM, Melief CJ (1991) Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses. Eur J Immunol 21:2963-2970
110. Nair SK, Snyder D, Gilboa E (1996) Cells treated with TAP-2 antisense oligonucleotides are potent antigen-presenting cells in vitro and in vivo. J Immunol 156:1772-1780